Citations

Clear

426 citation(s) found for "ST, Reza".

An Iranian family with Alzheimer’s disease caused by a novel APP mutation (Thr714Ala)
Najmabadi, Hossein , Noorian, Ali Reza , Moghimi, Babak, Jannati, Ali , Soltanzadeh, A., Krefft, Thomas A., Hardy, John , Pasalar, Parvin , Crook, Richard , Hardy, John

Mayo Clinic

Neurology | May 13, 2012 | Volume: 58 | Issue: 10 | Pages: 1574-1575

10.1212/wnl.58.10.1574 | PMID 12034808 Get It

Pitch Velocity Is a Predictor of Medial Elbow Distraction Forces in the Uninjured High School–Aged Baseball Pitcher
Hurd, Wendy J., Jazayeri, Reza, Mohr, Karen , Limpisvasti, Orr , ElAttrache, Neal S., Kaufman, Kenton R. , Kaufman, Kenton R

Mayo Clinic

Sports Health: A Multidisciplinary Approach | March 23, 2012 | Volume: 4 | Issue: 5 | Pages: 415-418

10.1177/1941738112439695 | PMID 23016114 Get It

Background: Medial elbow injuries are common among baseball pitchers. Easily accessed methods to assess medial elbow stress may be useful in identifying individuals with increased injury risk. Hypothesis: Pitch velocity (PV) is positively associated with higher medial elbow adduction moments. Study Design: Cohort study; Level of evidence, 2. Methods: Participants included 26 uninjured high school pitchers, 15 to 18 years in age. Three-dimensional data and PV were collected as athletes threw 10 fastballs for strikes to a regulation-distance target. Variables of interest were the normalized peak internal elbow adduction moment and peak PV. Linear regression was performed to evaluate the influence of PV on the adduction moment. Results: For the group, mean PV was 71 mph (range, 58-81 mph), and the adduction moment was 0.558 Nm/Ht × mass (range, 0.378-0.723). PV was positively associated with the adduction moment ( P < 0.01, R 2 = 0.373). Conclusions: Talented young pitchers may be more susceptible to elbow injuries as a consequence of a biomechanical coupling between PV and upper extremity joint moments. Clinical Relevance: PV may be measured easily and serve as an indicator of medial elbow stress.
Photoselective Vaporization Prostatectomy: Experience With a Novel 180 W 532 nm Lithium Triborate Laser and Fiber Delivery System in Living Dogs
Malek, Reza S., Peng, Yihlih Steven, Stinson, Douglas, Beck, Michael , Koullick, Ed, Kang, Hyun Wook

Mayo Clinic

Journal of Urology | December 20, 2010 | Volume: 185 | Issue: 2 | Pages: 712-718

10.1016/j.juro.2010.09.076 | PMID 21168876 Get It

Greenlight Photoselective 120-Watt 532-nm Lithium Triborate Laser Vaporization Prostatectomy in Living Canines
Malek, Reza S., Coad, James E. , Koullick, Ed, Kang, Hyun Wook

Mayo Clinic

Journal of Endourology | April 16, 2009 | Volume: 23 | Issue: 5 | Pages: 837-845

10.1089/end.2008.0669 | PMID 19371169 Get It

Purpose: Efficiency, anatomic, and histopathologic outcomes of GreenLight™ HPS™ 120-W, 532-nm lithium triborate (LBO) laser photoselective vaporization of the prostate (PVP) in a survival model of living canines were studied and compared with the outcomes of the only benchmarked survival study of 60-W 532-nm potassium-titanyl-phosphate (KTP) laser PVP in living canines. Materials and Methods: Twelve dogs underwent anterograde PVP with the 120-W LBO laser and, 4 each, were euthanized 3 hours (acute), 3 days (early), or 8 weeks (chronic) postoperatively. Laser energy and time were recorded. Prostates were sectioned, measured, and histologically analyzed after hematoxylin and eosin (H&E), triphenyltetrazolium chloride (TTC), or Gomori trichrome (GT) staining and compared with a normal control. Results: LBO laser PVP at 120 W acutely created a 6.7 ± 3.2 cm 3 cavity, hemostatically, and vaporized tissue 160% more efficiently (mean 1.3 cm 3 /min vs 0.5 cm 3 /min), 500% faster (mean 4.9 vs 29.1 min), and needed 121% less energy (mean 28.8 vs 63.6 kJ) than the 60-W KTP laser. Histologic staining with H&E and TTC demonstrated a coagulation zone of 1.5 ± 0.3 mm for the 120-W LBO laser, comparable to the 1 to 2 mm for the 60-W KTP laser. H&E- and GT-stained, healed prostates at 8-weeks postoperatively showed reepithelialized cavities with minimal submucosal fibrosis compared with an identically stained normal and the benchmarked KTP laser PVP-treated prostates. Conclusion: Our in vivo canine survival study demonstrates GreenLight HPS 120-W, 532-nm LBO laser PVP has substantially more vaporization efficiency and speed, with equally favorable tissue interaction and healing vis-à-vis those benchmarked for the 532-nm wavelength by KTP laser PVP.
Laser Vaporization of Bovine Prostate: A Quantitative Comparison of Potassium-Titanyl-Phosphate and Lithium Triborate Lasers
Jebens, D. S., Malek, Reza S., Mitchell, G., Koullick, Ed, Kang, Hyun Wook

Mayo Clinic

Journal of Urology | December 17, 2008 | Volume: 180 | Issue: 6 | Pages: 2675-2680

10.1016/j.juro.2008.08.009 | PMID 18951570 Get It

Cyproheptadine displays preclinical activity in myeloma and leukemia
Mao, Xinliang , Liang, Sheng-Ben, Hurren, Rose, Gronda, Marcela, Chow, Sue, Xu, Gang , Zavareh, Reza Beheshti , Jamal, Nazir, Messner, Hans A., Hedley, David W. , Datti, Alessandro , Wrana, Jeffrey L. , Zhu, Yuanxiao, Shi, Chang-Xin, Tiedemann, Rodger E. , Trudel, Suzanne , Stewart, A. Keith , Schimmer, Aaron D. , Liang, Sheng‐Ben , Wang, Xiaoming , Lee, Kyle

Mayo Clinic

Blood | May 24, 2008 | Volume: 112 | Issue: 3 | Pages: 760-769

10.1182/blood-2008-02-142687 | PMID 18502826 Get It

AbstractD-cyclins are regulators of cell division that act in a complex with cyclin-dependent kinases to commit cells to a program of DNA replication. D-cyclins are overexpressed in many tumors, including multiple myeloma and leukemia, and contribute to disease progression and chemoresistance. To better understand the role and impact of D-cyclins in hematologic malignancies, we conducted a high throughput screen for inhibitors of the cyclin D2 promoter and identified the drug cyproheptadine. In myeloma and leukemia cells, cyproheptadine decreased expression of cyclins D1, D2, and D3 and arrested these cells in the G0/G1 phase. After D-cyclin suppression, cyproheptadine induced apoptosis in myeloma and leukemia cell lines and primary patient samples preferentially over normal hematopoietic cells. In mouse models of myeloma and leukemia, cyproheptadine inhibited tumor growth without significant toxicity. Cyproheptadine-induced apoptosis was preceded by activation of the mitochondrial pathway of caspase activation and was independent of the drug's known activity as an H1 histamine and serotonin receptor antagonist. Thus, cyproheptadine represents a lead for a novel therapeutic agent for the treatment of malignancy. Because the drug is well tolerated and already approved in multiple countries for clinical use as an antihistamine and appetite stimulant, it could be moved directly into clinical trials for cancer.
Malignant tumors of the spermatic cord
Malek, Reza S., Utz, David C., Farrow, George M., Malek, Reza S., Utz, David C., Farrow, George M.

Mayo Clinic

Cancer | June 29, 2006 | Volume: 29 | Issue: 4 | Pages: 1108-1113

10.1002/1097-0142(197204)29:4<1108::aid-cncr2820290461>3.0.co;2-# | PMID 5062867 Get It

Renal Cell Carcinoma in the Solitary Kidney: An Analysis of Complications and Outcome After Nephron Sparing Surgery
Ghavamian, Reza , Cheville, John C. , Lohse, Christine M. , Weaver, Amy L. , Zincke, Horst, Blute, Michael L.

Mayo Clinic

Journal of Urology | February 2, 2006 | Volume: 168 | Issue: 2 | Pages: 454-459

10.1016/s0022-5347(05)64657-5 | PMID 12131287 Get It

EOSINOPHILIC CYSTITIS IN ADULTS
ITANO, NANCY M. B., Malek, Reza S.

Mayo Clinic

Journal of Urology | January 18, 2006 | Volume: 165 | Issue: 3 | Pages: 805-807

10.1016/s0022-5347(05)66531-7 Get It

Primary Localized Amyloidosis of The bladder:: Experience With Dimethyl Sulfoxide Therapy
Malek, Reza S., Wahner‐Roedler, Dietlind L. , Kyle, Robert A. , Gertz, Morie A.

Mayo Clinic

Journal of Urology | January 18, 2006 | Volume: 168 | Issue: 3 | Pages: 1018-1020

10.1016/s0022-5347(05)64564-8 | PMID 12187212 Get It